The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,180.00
Bid: 2,190.00
Ask: 2,195.00
Change: -45.00 (-2.02%)
Spread: 5.00 (0.228%)
Open: 2,235.00
High: 2,270.00
Low: 2,170.00
Prev. Close: 2,225.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

12 Oct 2023 07:00

RNS Number : 8500P
Oxford Instruments PLC
12 October 2023
 
Oxford Instruments plc

Half Year Trading Update - 12 October 2023

 

This announcement contains inside information.

 

Robust overall demand and order book visibility. Full year trading anticipated towards the lower end of expectations

 

Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2023.

 

Our differentiated positions in key structural growth markets including advanced materials, life science, compound semiconductor, and quantum technology are continuing to generate positive results overall.

 

Revenue is ahead of the first half of last year, with particularly good growth in Research & Discovery. Growth in Materials & Characterisation has been tempered by some softness in higher margin segments. Orders for the first half of the financial year are expected to be slightly behind a strong comparator period (HY23: up 18.7%), with some timing delays to anticipated customer orders impacting the first half. However, we expect to report good order book growth for the half year, reflecting a positive book-to-bill of approximately 1.07.

 

A currency headwind and continued investment in infrastructure, operational capability and capacity means that adjusted operating profit1 for the first six months of the year will be broadly in line with last year. We anticipate that this will result in a slightly reduced margin for the half year.

 

While we remain mindful of the current macro-economic and political climate, our order book for the remainder of FY23/24 is strong and supported by a robust pipeline. Our operational improvement programme is expected to support an increase in production alongside our normal seasonal second half weighting. This provides good visibility for an expected improvement in trading, with full year trading towards the lower end of expectations.

 

Oxford Instruments' results for the half year ending 30 September 2023 will be released on 14 November 2023.

  

 

Notes:

 

1. Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, and the mark-to-market revaluation of financial derivatives

2. Oxford Instruments compiled analyst forecast range for adjusted operating profit (year to 31 March 2024) is £78.6m to £84.3m, with consensus at £82.8m

  

Enquiries:

 

Oxford Instruments plc

Richard Tyson, Chief Executive

Gavin Hill, Chief Financial Officer

Julian Wais, Head of Investor Relations

Tel: 01865 393200

 

 

MHP

Tim Rowntree/Katie Hunt/Eleni Menikou

oxfordinstruments@mhpgroup.com

Tel: 020 3128 8100

 

- Ends -

 

Issued for and on behalf of Oxford Instruments plc

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and?supports high-technology products and systems which allow the world's leading companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level. The Group's products and services help its customers to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries across its key market segments: Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, Energy & Environment and Quantum Technology.?

 

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to enable a greener, healthier, more connected advanced society. Founded in 1959 as the first technology business to be spun out from?Oxford?University, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG). Its customer-centric, market-focused strategy creates competitive advantage through understanding the technical and commercial challenges in markets with long-term structural growth drivers.

 

For more information, visit www.oxinst.com? 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBNFBDDCKD
Date   Source Headline
24th Apr 20244:31 pmPRNHolding(s) in Company
24th Apr 20244:29 pmPRNHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
11th Apr 202412:54 pmPRNDirector/PDMR Shareholding
2nd Apr 202410:32 amPRNTotal Voting Rights
20th Mar 20244:26 pmPRNDirector/PDMR Shareholding
12th Mar 20248:30 amPRNDirector/PDMR Shareholding
1st Mar 20248:00 amPRNTotal Voting Rights
28th Feb 202411:25 amPRNHolding(s) in Company
12th Feb 20244:15 pmPRNDirector/PDMR Shareholding
1st Feb 20249:10 amPRNTotal Voting Rights
19th Jan 202411:30 amPRNHolding(s) in Company
11th Jan 20244:25 pmPRNDirector/PDMR Shareholding
10th Jan 20247:00 amRNSAcquisition of First Light Imaging SAS
2nd Jan 20241:31 pmPRNBlocklisting - Interim Review
2nd Jan 20241:19 pmPRNTotal Voting Rights
12th Dec 20239:00 amPRNDirector/PDMR Shareholding
1st Dec 20239:00 amPRNTotal Voting Rights
22nd Nov 20232:01 pmPRNAppointment of Independent Non-Executive Director
15th Nov 20234:42 pmPRNDirector/PDMR Shareholding
15th Nov 202312:29 pmPRNDirector/PDMR Shareholding
14th Nov 20237:00 amRNSHalf-Year Results
13th Nov 20231:37 pmPRNDirector/PDMR Shareholding
1st Nov 20239:00 amPRNTotal Voting Rights
17th Oct 20234:13 pmPRNHolding(s) in Company
12th Oct 20234:03 pmPRNDirector/PDMR Shareholding
12th Oct 20237:00 amRNSHalf Year Trading Update
11th Oct 20239:32 amPRNDirector/PDMR Shareholding
2nd Oct 20238:53 amPRNTotal Voting Rights
27th Sep 20234:19 pmPRNDirector/PDMR Shareholding
25th Sep 20234:20 pmPRNDirector/PDMR Shareholding
19th Sep 20231:41 pmPRNAnnual General Meeting 2023 Results
14th Sep 20237:00 amPRNBlock Listing Application
12th Sep 20233:27 pmPRNDirector/PDMR Shareholding
10th Aug 20232:16 pmPRNDirector/PDMR Shareholding
7th Aug 202310:35 amPRNHolding(s) in Company
1st Aug 20232:16 pmRNSTotal Voting Rights
27th Jul 20234:59 pmRNSHolding(s) in Company
27th Jul 20231:51 pmRNSCEO succession update
26th Jul 20235:12 pmRNSDirector/PDMR Shareholding
26th Jul 202311:15 amRNSHolding(s) in Company
25th Jul 202312:44 pmRNSDirector/PDMR Shareholding
20th Jul 202310:23 amPRNPublication of Annual Report and Notice of AGM 2023
10th Jul 20233:26 pmPRNDirector/PDMR Shareholding
6th Jul 20237:00 amRNSAnnual General Meeting: revised date
3rd Jul 20232:37 pmPRNBlocklisting - Interim Review
3rd Jul 20231:39 pmPRNTotal Voting Rights
13th Jun 20237:00 amRNSPreliminary Results
13th Apr 20237:00 amRNSCEO succession
13th Apr 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.